The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders

NE Chambers, M Millett Jr… - Biochemical Society …, 2023 - portlandpress.com
Barbeau's seesaw hypothesis of dopamine-acetylcholine balance has predominated
movement disorders literature for years. Both the simplicity of the explanation and the …

Psychosis as a disorder of muscarinic signalling: psychopathology and pharmacology

RA McCutcheon, LAE Weber, MM Nour… - The Lancet …, 2024 - thelancet.com
Dopaminergic receptor antagonism is a crucial component of all licensed treatments for
psychosis, and dopamine dysfunction has been central to pathophysiological models of …

Advances in targeting neurotransmitter systems in dystonia

D Steel, KM Reid, A Pisani, EJ Hess, S Fox… - International Review of …, 2023 - Elsevier
Dystonia is characterised as uncontrolled, often painful involuntary muscle contractions that
cause abnormal postures and repetitive or twisting movements. These movements can be …

A sex-specific effect of M4 muscarinic cholinergic autoreceptor deletion on locomotor stimulation by cocaine and scopolamine

A Berezovskaia, M Thomsen, A Fink-Jensen… - Frontiers in Molecular …, 2024 - frontiersin.org
Objective Acetylcholine modulates the activity of the direct and indirect pathways within the
striatum through interaction with muscarinic M4 and M1 receptors. M4 receptors are …

Multiple cholinergic receptor subtypes coordinate dual modulation of acetylcholine on anterior and posterior paraventricular thalamic neurons

Q Ye, J Nunez, X Zhang - Journal of Neurochemistry, 2024 - Wiley Online Library
Paraventricular thalamus (PVT) plays important roles in the regulation of emotion and
motivation through connecting many brain structures including the midbrain and the limbic …

Anticholinergic drugs for parkinsonism and other movement disorders

PA LeWitt, L Hong, MS Moehle - Journal of Neural Transmission, 2024 - Springer
Anticholinergic (AC) drugs, a medication class that acts by blocking nicotinic and muscarinic
acetylcholine receptors, were first utilized for therapeutic purposes in the mid-19th century …

Neuropathology and morphometry of dentate nucleus neurons in DYT1 brains: Cerebellar abnormalities in isolated dystonia

D Iacono, H Peng, ML Rabin… - Journal of Neuropathology …, 2023 - academic.oup.com
Brain lesions exclusive to dystonia, or specific forms of it, such as isolated dystonia, have
been rarely described. While the identification of distinctive intra-or extraneuronal …

Motor deficit and lack of overt dystonia in Dlx conditional Dyt1 knockout mice

D Berryman, J Barrett, C Liu, C Maugee… - Behavioural brain …, 2023 - Elsevier
Abstract DYT1 or DYT-TOR1A dystonia is early-onset generalized dystonia caused by a
trinucleotide deletion of GAG in the TOR1A or DYT1 gene leads to the loss of a glutamic acid …

[HTML][HTML] New drug treatments for schizophrenia: a review of approaches to target circuit dysfunction

OD Howes, E Dawkins, MC Lobo, SJ Kaar, K Beck - Biological Psychiatry, 2024 - Elsevier
Schizophrenia is a leading cause of global disease burden. Current drug treatments are
associated with significant side-effects and have limited efficacy for many patients; …

Transgenic mice for the translational study of neuropathic pain and dystonia

D Scuteri, K Hamamura, C Watanabe, P Tonin… - International journal of …, 2022 - mdpi.com
Murine models are fundamental in the study of clinical conditions and the development of
new drugs and treatments. Transgenic technology has started to offer advantages in …